LIAISON® ANDROSTENEDIONE - COFEPRIS Registration 1576R2018 SSA
Access comprehensive regulatory information for LIAISON® ANDROSTENEDIONE (LIAISON® ANDROSTENEDIONE) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1576R2018 SSA and manufactured by DIASORIN MÉXICO, S.A. DE C.V.. The device was registered on June 15, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL ENSAYO DIASORIN LIAISON® ANDROSTENEDIONE ES UN INMUNOENSAYO QUIMIOLUMINISCENTE (CLIA) DE DIAGNÓSTICO IN VITRO INDICADO PARA LA DETERMINACIÓN CUANTITATIVA DE Δ4-ANDROSTENEDIONA EN SUERO HUMANO Y PLASMA CON EDTA. LOS RESULTADOS DEL ENSAYO DEBEN UTIL
THE DIASORIN LIAISON® ANDROSTENEDIONE ASSAY IS AN IN VITRO DIAGNOSTIC CHEMILUMINESCENT IMMUNOASSAY (CLIA) INDICATED FOR THE QUANTITATIVE DETERMINATION OF Δ4-ANDROSTENEDIONE IN HUMAN SERUM AND PLASMA WITH EDTA. THE RESULTS OF THE TEST SHOULD BE USEFUL